Pre-season screening currently has no value for injury prediction: The development and internal validation of a multivariable prognostic model to predict indirect muscle injury risk in elite football (soccer) players

Background In elite football (soccer), periodic health examination (PHE) could provide prognostic factors to predict injury risk.

Objective To develop and internally validate a prognostic model to predict individual indirect (non-contact) muscle injury (IMI) risk during a season in elite footballers, only using PHE-derived candidate prognostic factors.

Methods Routinely collected preseason PHE and injury data were used from 119 players over 5 seasons (1^st July 2013 to 19^th May 2018). Ten candidate prognostic factors (12 parameters) were included in model development. Multiple imputation was used to handle missing values. The outcome was any time-loss, index indirect muscle injury (I-IMI) affecting the lower extremity. A full logistic regression model was fitted, and a parsimonious model developed using backward-selection to remove non-significant factors. Predictive performance was assessed through calibration, discrimination and decision-curve analysis, averaged across all imputed datasets. The model was internally validated using bootstrapping and adjusted for overfitting.

Results During 317 participant-seasons, 138 I-IMIs were recorded. The parsimonious model included only age and frequency of previous IMIs; apparent calibration was perfect but discrimination was modest (C-index = 0.641, 95% confidence interval (CI): 0.580 to 0.703), with clinical utility evident between risk thresholds of 37-71%. After validation and overfitting adjustment, performance deteriorated (C-index = 0.580; calibration-in-the-large =-0.031, calibration slope =0.663).

Conclusion The selected PHE data were insufficient prognostic factors from which to develop a useful model for predicting IMI risk in elite footballers. Further research should prioritise identifying novel prognostic factors to improve future risk prediction models in this field.

Trial registration number NCT03782389

KEY POINTS

• Factors measured through preseason screening generally have weak prognostic strength for future indirect muscle injuries and further research is needed to identify novel, robust prognostic factors.

• Because of sample size restrictions, and until the evidence base improves, it is likely that any further attempts at creating a prognostic model at individual club level would also suffer from poor performance.

• The value of using preseason screening data to make injury predictions or to select bespoke injury prevention strategies remains to be demonstrated, so screening should only be considered as useful for detection of salient pathology or for rehabilitation/ performance monitoring purposes at this time.